The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes
Abstract
A number of cytolytic T lymphocyte (CTL) clones derived from several melanoma patients have been found to recognize a majority of melanomas from HLA‐A2 patients. We have reported previously that two such CTL clones recognize a product of the tyrosinase gene that is presented by HLA‐A2. Here we show that one of these CTL clones recognizes a peptide encoded by the first nine amino acids of the putative signal sequence of tyrosinase. The other CTL clone recognizes a different tyrosinase peptide corresponding to amino acids 368–376. Both peptides contain consensus motifs of HLA‐A2 binding peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
In vitro methods in cell-mediated and tumor immunity
Bloom, B. R., & David, J. R. (1976) · Academic Press eBooks · Cited by 1,273
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,243
Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Brichard, V, Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., & Boon, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.489 · Cited by 950
Self-citationTraversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
Self-citationIn vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
Deres, K., Schild, H., Wiesmüller, K.-H., Jung, G., & Rammensee, H.-G. (1989) · Nature · doi:10.1038/342561a0 · Cited by 631
Identification of human cancers deficient in antigen processing.
Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mulé, J. J., Rosenberg, S. A., & Bennink, J. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.265 · Cited by 624
Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids
Salter, R. D., Howell, D. N., & Cresswell, P. (1985) · Immunogenetics · doi:10.1007/bf00375376 · Cited by 566
HLA-A2.1-Associated Peptides from a Mutant Cell Line: A Second Pathway of Antigen Presentation
Henderson, R. A., Michel, H., Sakaguchi, K., Shabanowitz, J., Appella, E., Hunt, D. F., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546329 · Cited by 520
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
Wei, M. L., & Cresswell, P. (1992) · Nature · doi:10.1038/356443a0 · Cited by 496
Muul, L. M., Spiess, P. J., Director, E. P., & Rosenberg, S. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.989 · Cited by 486
Acquisition of immunologic self-tolerance
Schwartz, R. H. (1989) · Cell · doi:10.1016/0092-8674(89)90044-5 · Cited by 477
Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.
Kwon, B. S., Haq, A. K., Pomerantz, S. H., & Halaban, R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7473 · Cited by 438
Kelly, A., Powis, S. H., Kerr, L.-A., Mockridge, I., Elliott, T., Bastin, J., Uchanska-Ziegler, B., Ziegler, A., Trowsdale, J., & Townsend, A. (1992) · Nature · doi:10.1038/355641a0 · Cited by 408
Atherton, E., Logan, C. J., & Sheppard, R. C. (1981) · J. Chem. Soc., Perkin Trans. 1 · doi:10.1039/p19810000538 · Cited by 400
Presentation of viral antigen controlled by a gene in the major histocompatibility complex
Cerundolo, V., Alexander, J., Anderson, K., Lamb, C., Cresswell, P., McMichael, A., Gotch, F., & Townsend, A. (1990) · Nature · doi:10.1038/345449a0 · Cited by 377
Kast, W. M., Roux, L., Curren, J., Blom, H. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D., & Melief, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2283 · Cited by 326
Spies, T., Cerundolo, V., Colonna, M., Cresswell, P., Townsend, A., & DeMars, R. (1992) · Nature · doi:10.1038/355644a0 · Cited by 321
Parham, P., & Brodsky, F. M. (1981) · Human Immunology · doi:10.1016/0198-8859(81)90065-3 · Cited by 320
De Plaen, E., Lurquin, C., Van Pel, A., Mariamé, B., Szikora, J. P., Wölfel, T., Sibille, C., Chomez, P., & Boon, T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2274 · Cited by 308
Self-citationLurquin, C., Van Pel, A., Mariamé, B., De Plaen, E., Szikora, J.-P., Janssens, C., Reddehase, M. J., Lejeune, J., & Boon, T. (1989) · Cell · doi:10.1016/0092-8674(89)90844-1 · Cited by 300
Self-citationFalk, K., Rötzschke, O., Deres, K., Metzger, J., Jung, G., & Rammensee, H. G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.2.425 · Cited by 266
Sequential chemoimmunotherapy in the treatment of metastatic melanoma.
Richards, J. M., Mehta, N., Ramming, K., & Skosey, P. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.8.1338 · Cited by 257
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
Itoh, K., Tilden, A. B., & Balch, C. M. (1986) · PubMed · Cited by 256
Peptide-induced antiviral protection by cytotoxic T cells.
Schulz, M., Zinkernagel, R. M., & Hengartner, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.991 · Cited by 238
Knuth, A., Danowski, B., Oettgen, H. F., & Old, L. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3511 · Cited by 236
Darrow, T. L., Slingluff, C. L., & Seigler, H. F. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.9.3329 · Cited by 214
Nijman, H. W., Houbiers, J. G. A., Vierboom, M. P. M., van der Burg, S. H., Drijfhout, J. W., D'Amaro, J., Kenemans, P., Melief, C. J. M., & Kast, W. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230603 · Cited by 193
Knuth, A., Wölfel, T., Klehmann, E., Boon, T., & Meyer zum Büschenfelde, K. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2804 · Cited by 188
Self-citationInduction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.
Bouchard, B., Fuller, B. B., Vijayasaradhi, S., & Houghton, A. N. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.6.2029 · Cited by 179
Prognostic Significance of Hypopigmentation in Malignant Melanoma
Bystryn, J.-C. (1987) · Archives of Dermatology · doi:10.1001/archderm.1987.01660320095019 · Cited by 171
Tsomides, T. J., Walker, B. D., & Eisen, H. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11276 · Cited by 162
Clonal analysis of cytotoxic T cell response against human melanoma.
Mukherji, B., & MacAlister, T. J. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.158.1.240 · Cited by 137
Slingluff, C. L., Cox, A. L., Henderson, R. A., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.2955 · Cited by 122
Bernard, H., Krämmer, G., & Röwekamp, W. G. (1985) · Experimental Cell Research · doi:10.1016/0014-4827(85)90446-x · Cited by 81
Tripathi, R. K., Giebel, L. B., Strunk, K. M., & Spritz, R. A. (1991) · Europe PMC (PubMed Central) · Cited by 75
Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones
Degiovanni, G., Lahaye, T., Hérin, M., Hainaut, P., & Boon, T. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180503 · Cited by 64
Self-citationBodmer, H. C., Ogg, G. S., Gotch, F. M., & McMichael, A. J. (1989) · Nature · doi:10.1038/342443a0 · Cited by 43
RFLP for TaqI at the human tyrosinase locus
Spritz, R. A., Strunk, K. M., Oetting, W. S., & King, R. A. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.20.9890 · Cited by 18
Cited by
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Self-citationTumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
Self-citationHuman tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
Self-citation
Metadata
- Authors
- Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Zum Büschenfelde, K. M., & Boon, T.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1994-03
- Volume
- 24
- Issue
- 3
- Pages
- 759-764
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1965517166
- Cited by
- 411
- References
- 40
- FWCI
- 16.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.